Citizens reiterates Fermi stock rating amid board dispute

Citizens reiterated a Market Outperform rating on Fermi with a $30 price target, implying about 8.5x 2028 estimated EV/EBITDA versus a $6.06 share price. The article also highlights a $189 million Q1 2026 net loss, missed revenue expectations, and $1.05 billion in negative free cash flow over the last 12 months, underscoring cash burn and governance risk. Former CEO activism and a call for a dual-track sale process add to the uncertainty around the stock.

Analysis

FRMI is now a governance/event-driven special situation, not a clean fundamental long. The market is effectively discounting two competing paths: a distressed financing overhang if the current board stays in place, versus a control premium if an activist/Founder-led regime forces a strategic process. The key second-order issue is that the equity’s upside is highly convex but only if the company can avoid a value-destructive, single-counterparty commercialization path that would likely cap optionality and weaken negotiating leverage.

The more important near-term catalyst is not the price target, but the board process itself. If the former CEO can credibly rally enough holder support to force a shakeup, the stock could rerate quickly on expectations of a broader sale or multi-tenant monetization strategy; if he fails, the equity likely trades back toward cash-burn optics and dilution risk. With negative free cash flow still so large relative to enterprise value, every quarter of delay meaningfully reduces the probability of a clean equity outcome, so timing matters more than valuation.

The contrarian read is that the stock may already embed some takeover optionality, but not enough probability-weighted downside from execution slippage. Consensus likely underestimates how quickly governance fights can destroy deal certainty: strategic buyers usually wait for clarity, and lenders/partners may demand harsher terms while the process is contested. That means the best trade is not a blind long; it is a catalyst-timed position with defined downside, because the binary outcome could resolve over weeks, while operational bleed persists over months.

CIA is effectively irrelevant here as a direct name, but the broader theme is that activist pressure can surface hidden value only when paired with credible financing and a fast path to commercialization. Absent that, activism becomes a time tax on a cash-burning asset. The real tell will be whether management can announce a first scaled customer or a process with multiple bidders before liquidity becomes the dominant narrative.

Key Decisions for Investors

• Speculative long FRMI only via call spreads or a small starter equity position ahead of any board vote; target 2-3x if a sale process is credibly launched, but cap risk because downside remains driven by dilution and cash burn.
• If already long FRMI, hedge with near-dated puts or reduce into strength until governance clarity improves; the trade should be sized like a binary event, not a valuation story.
• Watch for a tactical long entry only on confirmation of a multi-tenant/customer announcement or independent board review; that would improve negotiating leverage and justify a rerating over the next 1-2 quarters.
• Avoid initiating an unhedged short solely on valuation; this is a squeeze-prone special situation where any credible strategic-process headline can gap the stock sharply higher.